325 related articles for article (PubMed ID: 38021357)
1. Surgical management of pancreatic ductal adenocarcinoma: a narrative review.
Sarfaty E; Khajoueinejad N; Zewde MG; Yu AT; Cohen NA
Transl Gastroenterol Hepatol; 2023; 8():39. PubMed ID: 38021357
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan.
Ei S; Takahashi S; Ogasawara T; Mashiko T; Masuoka Y; Nakagohri T
Gut Liver; 2023 Sep; 17(5):698-710. PubMed ID: 36843421
[TBL] [Abstract][Full Text] [Related]
3. Minimally invasive versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: Individual patient data meta-analysis of randomized trials.
Uijterwijk BA; Wei K; Kasai M; Ielpo B; Hilst JV; Chinnusamy P; Lemmers DHL; Burdio F; Senthilnathan P; Besselink MG; Abu Hilal M; Qin R
Eur J Surg Oncol; 2023 Aug; 49(8):1351-1361. PubMed ID: 37076411
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. A comparison of minimally invasive vs open distal pancreatectomy for resectable pancreatic ductal adenocarcinoma: Propensity score matching analysis.
Kwon J; Park SY; Park Y; Jun E; Lee W; Song KB; Lee JH; Hwang DW; Kim SC
J Hepatobiliary Pancreat Sci; 2021 Nov; 28(11):967-982. PubMed ID: 33091208
[TBL] [Abstract][Full Text] [Related]
6. Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review.
Taherian M; Wang H
Chin Clin Oncol; 2022 Jun; 11(3):21. PubMed ID: 35726190
[TBL] [Abstract][Full Text] [Related]
7. Robotic
Feng Q; Jiang C; Feng X; Du Y; Liao W; Jin H; Liao M; Zeng Y; Huang J
Front Oncol; 2021; 11():752236. PubMed ID: 34616686
[TBL] [Abstract][Full Text] [Related]
8. [Chinese expert consensus on minimally invasive radical surgery for pancreatic ductal adenocarcinoma (version 2022)].
;
Zhonghua Wai Ke Za Zhi; 2023 Mar; 61(3):187-195. PubMed ID: 36650963
[TBL] [Abstract][Full Text] [Related]
9. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
[TBL] [Abstract][Full Text] [Related]
10. Vascular Resection for Pancreatic Cancer: 2019 French Recommendations Based on a Literature Review From 2008 to 6-2019.
Delpero JR; Sauvanet A
Front Oncol; 2020; 10():40. PubMed ID: 32117714
[No Abstract] [Full Text] [Related]
11. Technical advances in surgery for pancreatic cancer.
Schneider M; Hackert T; Strobel O; Büchler MW
Br J Surg; 2021 Jul; 108(7):777-785. PubMed ID: 34046668
[TBL] [Abstract][Full Text] [Related]
12. Minimally invasive surgery for pancreatic cancer-are we there yet?-a narrative review.
Bhandare MS; Parray A; Chaudhari VA; Shrikhande SV
Chin Clin Oncol; 2022 Feb; 11(1):3. PubMed ID: 35255692
[TBL] [Abstract][Full Text] [Related]
13. Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA): study protocol for a randomized controlled trial.
van Hilst J; Korrel M; Lof S; de Rooij T; Vissers F; Al-Sarireh B; Alseidi A; Bateman AC; Björnsson B; Boggi U; Bratlie SO; Busch O; Butturini G; Casadei R; Dijk F; Dokmak S; Edwin B; van Eijck C; Esposito A; Fabre JM; Falconi M; Ferrari G; Fuks D; Groot Koerkamp B; Hackert T; Keck T; Khatkov I; de Kleine R; Kokkola A; Kooby DA; Lips D; Luyer M; Marudanayagam R; Menon K; Molenaar Q; de Pastena M; Pietrabissa A; Rajak R; Rosso E; Sanchez Velazquez P; Saint Marc O; Shah M; Soonawalla Z; Tomazic A; Verbeke C; Verheij J; White S; Wilmink HW; Zerbi A; Dijkgraaf MG; Besselink MG; Abu Hilal M;
Trials; 2021 Sep; 22(1):608. PubMed ID: 34503548
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
15. Borderline resectable pancreatic cancer.
Hackert T; Ulrich A; Büchler MW
Cancer Lett; 2016 Jun; 375(2):231-237. PubMed ID: 26970276
[TBL] [Abstract][Full Text] [Related]
16. The role of intraperitoneal chemotherapy in the surgical management of pancreatic ductal adenocarcinoma: a systematic review.
Brind'Amour A; Webb M; Parapini M; Sidéris L; Segedi M; Chung SW; Chartier-Plante S; Dubé P; Scudamore CH; Kim PTW
Clin Exp Metastasis; 2021 Apr; 38(2):187-196. PubMed ID: 33486670
[TBL] [Abstract][Full Text] [Related]
17. Second pancreatectomy for recurrent pancreatic ductal adenocarcinoma in the remnant pancreas: A pooled analysis.
Zhou Y; Song A; Wu L; Si X; Li Y
Pancreatology; 2016; 16(6):1124-1128. PubMed ID: 27717684
[TBL] [Abstract][Full Text] [Related]
18. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
Shi HJ; Jin C; Fu DL
World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
[TBL] [Abstract][Full Text] [Related]
19. A patient-centered, multidisciplinary approach to treating borderline resectable pancreatic adenocarcinoma.
Hester CA; Katz MHG
Chin Clin Oncol; 2022 Dec; 11(6):45. PubMed ID: 36509553
[TBL] [Abstract][Full Text] [Related]
20. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study.
Lee DH; Ha HI; Jang JY; Lee JW; Choi JY; Bang S; Lee CH; Kim WB; Lee SS; Kim SC; Kang BK; Lee JM
Eur Radiol; 2023 Sep; 33(9):5965-5975. PubMed ID: 36988715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
